Unravelling the molecular basis for regulatory T‐cell plasticity and loss of function in disease. Issue 2 (27th February 2018)

• Record Type: Journal Article
• Authors: Sadlon, Timothy; Brown, Cheryl Y; Bandara, Veronika; Hope, Christopher M; Schjenken, John E; Pederson, Stephen M; Breen, James; Forrest, Alistair; Beyer, Marc; Robertson, Sarah; Barry, Simon C
• Is Part Of: Clinical & translational immunology. Volume 7:Issue 2(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-02-27
• Subjects: gene regulation -- genetic risk of disease -- microRNA -- T‐cell fate -- T‐cell plasticity -- Treg FOXP3; Immunologic diseases -- Periodicals; Immunology -- Periodicals; Clinical medicine -- Periodicals; Immune System Diseases -- therapy; Immunotherapy; Immunologic Factors -- therapeutic use; Translational Medical Research; Molecular Targeted Therapy; Clinical medicine; Immunologic diseases; Immunology; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 616.079
• DOI: 10.1002/cti2.1011
• Languages: English
• ISSNs: 2050-0068

Abstract

Abstract: Regulatory T cells (Treg) are critical for preventing autoimmunity and curtailing responses of conventional effector T cells (Tconv). The reprogramming of T‐cell fate and function to generate Treg requires switching on and off of key gene regulatory networks, which may be initiated by a subtle shift in expression levels of specific genes. This can be achieved by intermediary regulatory processes that include microRNA and long noncoding RNA‐based regulation of gene expression. There are well‐documented microRNA profiles in Treg and Tconv, and these can operate to either reinforce or reduce expression of a specific set of target genes, including FOXP3 itself. This type of feedforward/feedback regulatory loop is normally stable in the steady state, but can alter in response to local cues or genetic risk. This may go some way to explaining T‐cell plasticity. In addition, in chronic inflammation or autoimmunity, altered Treg/Tconv function may be influenced by changes in enhancer–promoter interactions, which are highly cell type‐specific. These interactions are impacted by genetic risk based on genome‐wide association studies and may cause subtle alterations to the gene regulatory networks controlled by or controlling FOXP3 and its target genes. Recent insights into the 3D organisation of chromatin and the mapping of noncoding regulatory regions to the genes they control are shedding new light on the direct impact of genetic risk on T‐cell function and susceptibility to inflammatory and autoimmune conditions. Abstract : The ability of human regulatory T cells to adapt to external cues and alter function requires transcriptional reprogramming to alter phenotype. This review discusses the possible mechanism underpinning this, whereby microRNAs act as a rheostat of the sentinel transcription factors that define function. The contribution of disease‐associated genetic variation to this process is also discussed.